Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Snertinge Dyrehospital ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.3% 1.7% 2.4% 2.0% 1.7% 1.8% 11.4% 11.2%   Credit score (0-100)   57 74 63 67 73 71 21 22   Credit rating   BBB A BBB A A A BB BB   Credit limit (kDKK)   0.0 2.5 0.0 0.2 2.9 1.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,329 5,623 6,076 5,811 5,064 5,516 0.0 0.0   EBITDA   616 722 1,014 603 666 902 0.0 0.0   EBIT   234 337 601 355 411 638 0.0 0.0   Pre-tax profit (PTP)   211.7 325.5 601.2 354.4 404.0 638.3 0.0 0.0   Net earnings   163.5 253.8 468.7 281.7 322.1 498.7 0.0 0.0   Pre-tax profit without non-rec. items   212 325 601 354 404 638 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   628 355 363 400 470 358 0.0 0.0   Shareholders equity total   718 1,072 953 835 857 1,056 506 506   Interest-bearing liabilities   624 73.3 3.0 17.3 94.1 2.9 0.0 0.0   Balance sheet total (assets)   2,685 2,604 3,380 2,021 2,148 1,936 506 506   Net Debt   383 -616 -1,568 -266 -376 -651 -256 -256     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,329 5,623 6,076 5,811 5,064 5,516 0.0 0.0   Gross profit growth   -0.5% 5.5% 8.1% -4.4% -12.8% 8.9% -100.0% 0.0%   Employees   0 0 14 13 12 12 0 0   Employee growth %   0.0% 0.0% 0.0% -7.1% -7.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,685 2,604 3,380 2,021 2,148 1,936 506 506   Balance sheet change%   -10.8% -3.0% 29.8% -40.2% 6.2% -9.8% -73.9% 0.0%   Added value   615.6 722.4 1,014.2 602.7 658.5 901.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -582 -783 -530 -335 -310 -501 -358 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   4.4% 6.0% 9.9% 6.1% 8.1% 11.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.7% 14.0% 21.2% 14.0% 20.3% 31.9% 0.0% 0.0%   ROI %   17.9% 26.9% 55.3% 38.6% 43.5% 61.1% 0.0% 0.0%   ROE %   23.8% 28.4% 46.3% 31.5% 38.1% 52.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   26.8% 41.2% 28.2% 41.3% 39.9% 54.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   62.2% -85.3% -154.6% -44.1% -56.5% -72.2% 0.0% 0.0%   Gearing %   86.9% 6.8% 0.3% 2.1% 11.0% 0.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.4% 13.1% 84.3% 228.9% 36.1% 25.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.8 0.9 0.7 0.7 1.1 0.0 0.0   Current Ratio   0.9 1.1 1.0 1.0 1.1 1.6 0.0 0.0   Cash and cash equivalent   241.1 689.4 1,571.4 283.1 470.3 653.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -158.3 79.0 41.3 7.3 87.6 494.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 72 46 55 75 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 72 46 56 75 0 0   EBIT / employee   0 0 43 27 34 53 0 0   Net earnings / employee   0 0 33 22 27 42 0 0